🇺🇸 FDA
Patent

US 10183944

Pyrimido-pyridazinone compounds and methods of use thereof

granted A61KA61K31/519A61P

Quick answer

US patent 10183944 (Pyrimido-pyridazinone compounds and methods of use thereof) held by Asana BioSciences, LLC expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Asana BioSciences, LLC
Grant date
Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/519, A61P, A61P11/06, A61P17/00